Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$12.23B
↑ 54% above average
Average (9y)
$7.92B
Historical baseline
Range
High:$13.35B
Low:$3.64B
CAGR
+14.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $12.23B | +12.5% |
| 2023 | $10.87B | +3.9% |
| 2022 | $10.47B | -21.6% |
| 2021 | $13.35B | +86.9% |
| 2020 | $7.14B | +27.9% |
| 2019 | $5.58B | -8.9% |
| 2018 | $6.13B | +15.0% |
| 2017 | $5.33B | +19.6% |
| 2016 | $4.46B | +22.5% |
| 2015 | $3.64B | - |